DR. CONSTANTINE PAPAGEORGIOU JOINS SENTIER AS CHIEF DATA SCIENTIST

Sentier, a leading sales and marketing AI solutions company for life sciences, welcomes Constantine Papageorgiou as its new Chief Data Scientist. Constantine’s cross-industry experience includes satellite image processing, quantitative investment management, and pharmaceutical sales and marketing analytics. His impressive background in applying machine learning to business questions will help Sentier continue to deliver the best possible data-driven insights to its clients. 

“We’re excited to have such a seasoned AI expert join us to head up our data science activities and take a leadership role in the company. We have worked closely with Constantine for the last two years and the formal position will only further his ability to innovate as we enter the omnichannel era in pharma. He is a unique “people-friendly” Ph.D. who can not only run with the best of the experts, but can bring it down to layman’s terms so stakeholders can understand the mechanics and benefits of the approaches we are using” notes Richard Sokolosky, CEO & Co-Founder of Sentier.

Constantine received a B.S. in Mathematics/Computer Science from Carnegie Mellon University and S.M. and Ph.D. degrees in Computer Science from MIT. He is also a CFA® Charterholder. 

——————

SENTIER was founded in 2017 to disrupt analytic insight generation and delivery in Pharma. Through VELOCITY, the industry leading Analytic Operations as a Service (AOaaS) platform, our customers are able to maximize the ROI on AI and ML activities by allowing non-data scientists to deliver answers as frequently as the business demands.  We also support our clients with advanced marketing & sales analytics and support services designed to prepare models and data pipelines for production.SENTIER believes that the ethical application of solutions will benefit patients and health care providers as well as the Pharma and Biotech companies we work with.